{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:40:31Z","timestamp":1768038031135,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12928-024-01073-7","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:42:27Z","timestamp":1734612147000},"page":"287-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Tineke H.","family":"Pinxterhuis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline H.","family":"Ploumen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Schotborgh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger L.","family":"Anthonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Roguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Danse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Benit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Aminian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard C. M.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Geelkerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine J. M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-2832","authenticated-orcid":false,"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"5","key":"1073_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/CIRCINTERVENTIONS.109.860494","volume":"2","author":"B Ahmed","year":"2009","unstructured":"Ahmed B, Piper WD, Malenka D, VerLee P, Robb J, Ryan T, et al. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv. 2009;2(5):423\u20139. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.109.860494.","journal-title":"Circ Cardiovasc Interv"},{"issue":"127","key":"1073_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.112.108290","volume":"5","author":"B Ahmed","year":"2013","unstructured":"Ahmed B, Dauerman HL. Women, bleeding, and coronary intervention. Circulation. 2013;5(127):641\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.108290.","journal-title":"Circulation"},{"issue":"9","key":"1073_CR3","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1538-7836.2011.04437.x","volume":"9","author":"S Achterberg","year":"2011","unstructured":"Achterberg S, Visseren FL, Kappelle LJ, Pruissen DM, Van Der Graaf Y, Algra A, et al. Differential propensity for major hemorrhagic events in patients with different types of arterial disease. J Thromb Haemost. 2011;9(9):1724\u20139. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04437.x.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1073_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-001004","volume":"6","author":"R Attar","year":"2019","unstructured":"Attar R, Wester A, Koul S, Eggert S, Andell P. Peripheral artery disease and outcomes in patients with acute myocardial infarction. Open heart. 2019;6(1): e001004. https:\/\/doi.org\/10.1136\/openhrt-2018-001004.","journal-title":"Open heart"},{"issue":"3","key":"1073_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jjcc.2019.07.015","volume":"75","author":"M Sasaki","year":"2020","unstructured":"Sasaki M, Mitsutake Y, Ueno T, Fukami A, Sasaki KI, Yokoyama S, et al. Low ankle brachial index predicts poor outcomes including target lesion revascularization during the long-term follow up after drug-eluting stent implantation for coronary artery disease. J Cardiol. 2020;75(3):250\u20134. https:\/\/doi.org\/10.1016\/j.jjcc.2019.07.015.","journal-title":"J Cardiol"},{"issue":"9","key":"1073_CR6","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","volume":"96","author":"SV Rao","year":"2005","unstructured":"Rao SV, O\u2019Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96(9):1200\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2005.06.056.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1073_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/eurheartj\/ehn358","volume":"30","author":"A Budaj","year":"2009","unstructured":"Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP, et al. Improving clinical outcomes by reducing bleeding in patients with non-st-elevation acute coronary syndromes. Eur Heart J. 2009;30(6):655\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehn358.","journal-title":"Eur Heart J"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2022.05.002","volume":"355","author":"TH Pinxterhuis","year":"2022","unstructured":"Pinxterhuis TH, Ploumen EH, Zocca P, Doggen CJM, Schotborgh CE, Anthonio RL, et al. Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: a patient-level pooled analysis of four randomized trials. Atherosclerosis. 2022;355:52\u20139. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.05.002.","journal-title":"Atherosclerosis"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2022.12.009","volume":"374","author":"TH Pinxterhuis","year":"2022","unstructured":"Pinxterhuis TH, Ploumen EH, Zocca P, Doggen CJM, Schotborgh CE, Anthonio RL, et al. Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease. Int J Cardiol. 2022;374:27\u201332. https:\/\/doi.org\/10.1016\/j.ijcard.2022.12.009.","journal-title":"Int J Cardiol"},{"issue":"10060","key":"1073_CR10","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","volume":"388","author":"C von Birgelen","year":"2016","unstructured":"von Birgelen C, Kok MM, van der Heijden LC, Danse PW, Schotborgh CE, Scholte M, et al. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (bio-resort): a three-arm, randomized, non-inferiority trial. Lancet. 2016;388(10060):2607\u201317.","journal-title":"Lancet"},{"issue":"10154","key":"1073_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0140-6736(18)32001-4","volume":"392","author":"C von Birgelen","year":"2018","unstructured":"von Birgelen C, Zocca P, Buiten RA, Jessurun GAJ, Schotborgh CE, Roguin A, et al. Thin composite wire strut, durable polymer-coated (resolute onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (orsiro) drug-eluting stents in allcomers with coronary artery disease (bionyx): an international, single-blind, randomised non-inferiority trial. Lancet. 2018;392(10154):1235\u201345.","journal-title":"Lancet"},{"issue":"123","key":"1073_CR12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"23","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;23(123):2736\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.009449.","journal-title":"Circulation"},{"issue":"17","key":"1073_CR13","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344\u201351. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.685313.","journal-title":"Circulation"},{"issue":"7","key":"1073_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.4244\/eijv5i7a146","volume":"5","author":"P Vranckx","year":"2010","unstructured":"Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity\u2014addendum to the historical Mi definitions used in stent studies. EuroIntervention. 2010;5(7):871\u20134. https:\/\/doi.org\/10.4244\/eijv5i7a146.","journal-title":"EuroIntervention"},{"issue":"1","key":"1073_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2013-000021","volume":"1","author":"CS Kwok","year":"2014","unstructured":"Kwok CS, Rao SV, Myint PK, Keavney B, Nolan J, Ludman PF, et al. Major bleeding after percutaneous coronary intervention and risk of subsequent mortality: a systematic review and meta-analysis. Open Heart. 2014;1(1): e000021. https:\/\/doi.org\/10.1136\/openhrt-2013-000021.","journal-title":"Open Heart"},{"issue":"16","key":"1073_CR16","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.109.858365","volume":"120","author":"ES van Hattum","year":"2009","unstructured":"van Hattum ES, Algra A, Lawson JA, Eikelboom BC, Moll FL, Tangelder MJ. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease. Circulation. 2009;120(16):1569\u201376. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.858365.","journal-title":"Circulation"},{"issue":"21","key":"1073_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013679","volume":"8","author":"N Ismail","year":"2019","unstructured":"Ismail N, Jordan KP, Kadam UT, Edwards JJ, Kinnaird T, Mamas MA. Bleeding after hospital discharge following acute coronary syndrome: incidence, types, timing, and predictors. J Am Heart Assoc. 2019;8(21): e013679. https:\/\/doi.org\/10.1161\/JAHA.119.013679.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1073_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention. Circulation. 2019;140(3):240\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040167.","journal-title":"Circulation"},{"issue":"11","key":"1073_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008708","volume":"7","author":"M Natsuaki","year":"2018","unstructured":"Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, et al. Prediction of thrombotic and bleeding events after percutaneous coronary intervention: Credo-Kyoto thrombotic and bleeding risk scores. J Am Heart Assoc. 2018;7(11): e008708. https:\/\/doi.org\/10.1161\/JAHA.118.008708.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1073_CR20","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1253\/circj.CJ-20-0253","volume":"84","author":"M Nakamura","year":"2020","unstructured":"Nakamura M, Kitazono T, Kozuma K, Sekine T, Nakamura S, Shiosakai K, et al. Prasugrel for Japanese patients with ischemic heart disease in long-term clinical practice (Prasfit-Practice Ii)- final 2-year follow-up results of a postmarketing observational study. Circ J. 2020;84(11):1981\u20139. https:\/\/doi.org\/10.1253\/circj.CJ-20-0253.","journal-title":"Circ J"},{"issue":"2","key":"1073_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jjcc.2019.01.008","volume":"74","author":"T Nakahashi","year":"2019","unstructured":"Nakahashi T, Tada H, Sakata K, Yakuta Y, Tanaka Y, Gamou T, et al. Impact of decreased ankle-brachial index on 30-day bleeding complications and long-term mortality in patients with acute coronary syndrome after percutaneous coronary intervention. J Cardiol. 2019;74(2):116\u201322. https:\/\/doi.org\/10.1016\/j.jjcc.2019.01.008.","journal-title":"J Cardiol"},{"issue":"5","key":"1073_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000497790","volume":"28","author":"I Al-Zakwani","year":"2019","unstructured":"Al-Zakwani I, Al Siyabi E, Alrawahi N, Al-Mulla A, Alnaeemi A, Shehab A, et al. Association between peripheral artery disease and major adverse cardiovascular events in patients with acute coronary syndrome: findings from the Gulf Coast Registry. Med Princ Pract. 2019;28(5):410\u20137. https:\/\/doi.org\/10.1159\/000497790.","journal-title":"Med Princ Pract"},{"issue":"3","key":"1073_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.004904","volume":"10","author":"R Gupta","year":"2017","unstructured":"Gupta R, Kirtane AJ, Ozan MO, Witzenbichler B, Rinaldi MJ, Metzger DC, et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents in subjects with peripheral arterial disease: analysis from the adapt-des study (assessment of dual antiplatelet therapy with drug-eluting stents). Circ Cardiovasc Interv. 2017;10(3): e004904. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.116.004904.","journal-title":"Circ Cardiovasc Interv"},{"issue":"100","key":"1073_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.amjcard.2007.03.035","volume":"3","author":"TY Wang","year":"2007","unstructured":"Wang TY, Chen AY, Roe MT, Alexander KP, Newby LK, Smith SC Jr, et al. Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-St-segment elevation acute coronary syndromes from the crusade quality improvement initiative. Am J Cardiol. 2007;3(100):391\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2007.03.035.","journal-title":"Am J Cardiol"},{"issue":"105","key":"1073_CR25","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.amjcard.2010.01.349","volume":"12","author":"S Kohsaka","year":"2010","unstructured":"Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, et al. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (Collaborative Study by Credo-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010;12(105):1698\u2013704. https:\/\/doi.org\/10.1016\/j.amjcard.2010.01.349.","journal-title":"Am J Cardiol"},{"issue":"64","key":"1073_CR26","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1016\/j.jacc.2014.08.048","volume":"23","author":"PO Jose","year":"2014","unstructured":"Jose PO, Frank AT, Kapphahn KI, Goldstein BA, Eggleston K, Hastings KG, et al. Cardiovascular disease mortality in Asian Americans. J Am Coll Cardiol. 2014;23(64):2486\u201394. https:\/\/doi.org\/10.1016\/j.jacc.2014.08.048.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-01073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-024-01073-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-024-01073-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T09:50:40Z","timestamp":1742032240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-024-01073-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1007\/s12928-024-01073-7","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"21 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Department of Thoraxcentrum Twente has received institutional research grants from Abbott Vascular, Biotronik, Boston Scientific, and Medtronic. RLA reports a teaching grant from Biotronik, a license from Sanofi, a speaking fee from Abiomed, and support from Amgen for attending a meeting, all outside the submitted work. All other authors declared that they have no relevant personal conflict of interest, related to the content of this study. All authors take responsibility for all aspects of the reliability and freedom from bias of the presented and their discussed interpretation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}